市场立即捐赠成为会员

购物车 (0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Tokyo Big Sight

2016 年 11 月 13 日 9:30 上午 - 2016 年 11 月 15 日 5:30 下午

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

13th DIA Japan Annual Meeting 2016

返回 Agenda

[V5-S2] How to Provide Drug Information from a Standpoint of a Patient (Part 1)

Session Chair(s)

Yuko Kojima, RPh

Yuko Kojima, RPh

Sr. Executive Director

Eli Lilly Japan K.K., Japan

Mamoru Narukawa, PhD, RPh

Mamoru Narukawa, PhD, RPh

Professor

Kitasato University, Japan

Determining what information patients and medical experts need, and how to make the information available to ensure proper drug use, is an essential issue. We will discuss various medical communication tools created by the pharmaceutical industry to encourage appropriate drug use (i.e., for medical experts, package inserts, interview forms, and guides for appropriate use; for patients, drug guides, and drug information sheets). This session will review the current situation, issues, and practice in Japan, discussed by speakers from the pharmaceutical industry, regulatory agencies, and HCPs. We will also exchange views on what information patients and medical experts need, and how to make this information available.

Speaker(s)

The Regulations of Drug Information Provision and its Challenges - From the Regulatory Agencies' Perspective

Tomoko Tanita

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Risk Communication Promotion Division, Office of Safety I

Junichi Nishino, MSc, RPh

The Current Status and the Issue of Drug Information Provision from the Pharmaceutical Industry Perspective

Junichi Nishino, MSc, RPh

Otsuka Pharmaceutical Co., Ltd., Japan

Head, Regulatory Affairs Department

The Current Status of the Providing Drug Information and Issue of the Medical Communication - The Point of View from Medical Site

Masahiro Hayashi, PhD

Toranomon Hospital, Japan

Pharmaceutical affairs specialist, Department of Pharmacy